[1] Schiffman M,Castle PE,Jeronimo J, Rodriguez AC, Wacholder S.Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907. doi: 10.1016/S0140-6736(07)61416-0.
[2] de Sanjose S,Quint WG,Alemany L, Geraets DT, Klaustermeier JE, Lloveras B,et al.Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.Lancet Oncol 2010;11: 1048-1056. doi: 10.1016/S1470-2045(10)70230-8.
[3] Kyrgiou M, Mitra A, Moscicki AB. Does the vaginal microbiota play a role in the development of cervical cancer?. Transl Res. 2017;179:168‐182. doi:10.1016/j.trsl.2016.07.004.
[4] You D, Han L, Li L, Hu J, Zimet GD, Alias H,et al.Human Papillomavirus (HPV) Vaccine Uptake and the Willingness to Receive the HPV Vaccination among Female College Students in China: A Multicenter Study.Vaccines (Basel) 2020;8.pii: E31.doi: 10.3390/vaccines8010031.
[5] Yang J, Wang W, Wang Z, Wang Z, Wang Y, Wang J,et al.Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women.Hum Vaccin Immunother 2019;6:1-8.doi: 10.1080/21645515.2019.1689743.
[6] Ciccarese G, Herzum A, Rebora A, Drago F.Prevalence of genital, oral, and anal HPV infection among STI patients in Italy.J Med Virol 2017;89:1121-1124. doi: 10.1002/jmv.24746.
[7] Audirac-Chalifour A, Torres-Poveda K, Bahena-Román M, Téllez-Sosa J, Martínez-Barnetche J, Cortina-Ceballos B, et al.Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.PLoS One 2016; 11:e0153274. doi: 10.1371/journal.pone.0153274.
[8] Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M.The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?Microbiome 2016;4:58. doi: 10.1186/s40168-016-0203-0.
[9] Lee JE,Lee S,Lee H, Song YM, Lee K, Han MJ, et al.Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One 2013; 8:e63514. doi:10.1371/journal.po ne.0063514.
[10] Brotman RM,Shardell MD,Gajer P, Tracy JK, Zenilman JM, Ravel J, et al.Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.J Infect Dis 2014;210:1723-1733.doi: 10.1093/infdis/jiu330.
[11] Chen C,Song X,Wei W, Zhong H, Dai J, Lan Z,et al.The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases.Nat Commun 2017;8:875. doi: 10.1038/s41467-017-00901-0.
[12] Adebamowo SN, Dareng EO, Famooto AO, Offiong R, Olaniyan O, Obende K,et al.Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME's) Human Papillomavirus (HPV) and Cervical Cancer Study.Int J Epidemiol 2017;46:1745-1745j. doi: 10.1093/ije/dyx050.
[13] Cong J, Zhang X. How human microbiome talks to health and disease. Eur J Clin Microbiol Infect Dis. 2018;37(9):1595‐1601. doi:10.1007/s10096-018-3263-1.
[14] Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature. 2019; 569(7758): 641‐648. doi:10.1038/s41586-019-1238-8.
[15] Witkin SS, Linhares IM.Why do lactobacilli dominate the human vaginal microbiota? BJOG 2017;124: 606-611. doi: 10.1111/1471-0528.14390.
[16] Godha K, Tucker KM, Biehl C,Archer DF, Mirkin S.Human vaginal pH and microbiota: an update.Gynecol Endocrinol 2018; 34:451-455. doi: 10.1080/09513590.2017.1407753.
[17] Kyrgiou M, Mitra A, Moscicki AB.Does the vaginal microbiota play a role in the development of cervical cancer?Transl Res 2017;179:168-182. doi: 10.1016/j.trsl.2016.07.004.
[18] Jin J.HPV Infection and Cancer.JAMA 2018;319:1058. doi: 10.1001/jama.2018.0687.
[19] Trottier H,Ferreira S,Thomann P, Costa MC, Sobrinho JS, Prado JC,et al.Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.Cancer Res 2010;70:8569-8577. doi: 10.1158/0008-5472.CAN-10-0621.
[20] Bui TC,Thai TN,Tran LT, Shete SS, Ramondetta LM, Basen-Engquist KM.Association Between Vaginal Douching and Genital Human Papillomavirus Infection Among Women in the United States.J Infect Dis 2016; 214:1370-1375. doi: 10.1093/infdis/jiw388.
[21] Borgdorff H, Tsivtsivadze E, Verhelst R, et al. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J. 2014;8(9):1781-1793. doi:10.1038/ismej.2014.26.
[22] Hardwick SA, Deveson IW, Mercer TR.Reference standards for next-generation sequencing.Nat Rev Genet 2017;18:473-484. doi: 10.1038/nrg.2017.44.
[23] Mitra A,MacIntyre DA,Lee YS, Smith A, Marchesi JR, Lehne B,et al.Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity.Sci Rep 2015;5:16865.doi:10.103 8/srep16865.
[24] Audirac-Chalifour A,Torres-Poveda K,Bahena-Román M,Téllez-Sosa J,Martínez-Barnetche J,Cortina- Ceballos B,et al.Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.PLoS One 2016;11:e0153274. doi: 10.1371/journal.pone.0153274.
[25] Oh HY,Kim BS,Seo SS,Kong JS, Lee JK, Park SY, et al.The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea.Clin Microbiol Infect 2015;21:674.e1-9. doi: 10.1016/j.cmi.2015.02.026.
[26] Degli Esposti M.Bioenergetic evolution in proteobacteria and mitochondria.Genome Biol Evol 2014;6: 3238-3251. doi: 10.1093/gbe/evu257.
[27] Werner J,Decarlo CA,Escott N, Zehbe I, Ulanova M.Expression of integrins and Toll-like receptors in cervical cancer: effect of infectious agents.Innate Immun 2012;18:55-69. doi: 10.1177/1753425910392934.
[28] Zhou L, Li H, Zhang Y, Han S, Xu H.Sphingomonas from petroleum-contaminated soils in Shenfu, China and their PAHs degradation abilities.Braz J Microbiol 2016;47:271-278. doi: 10.1016/j.bjm.2016.01.001.
[29] Zhang C, Luo Y, Zhong R,Law PTY, Boon SS, Chen Z,et al. Role of polycyclic aromatic hydrocarbons as a co-factor in human papillomavirus-mediated carcinogenesis.BMC Cancer 2019;19:138.doi:10.1186/s1288 5-019-5347-4.